medtech company News
-
Hyalex Named 2020 Emerging MedTech Company of the Year
Hyalex was named Emerging MedTech Company of the Year at the 2020 New England Venture Capital Association 2020 NEVYs Awards on December 1st, 2020. Click here to read more about the event and award ...
-
CorWave Joins the French Tech 120 Index, a Community That Brings Together the Top French Tech Scale-up Companies
Mr. Bruno Le Maire, Economy and Finance Minister and Mr. Cédric O, Secretary of State for Digital Transition and Electronic Communications, announced the selection of CorWave to join the French Tech 120 index, designed for the best French startups with the capacity to become global leaders. CorWave is one of five medtech startups selected in the French Tech 120 index. The French ...
By CorWave
-
Xeltis accelerating clinical trial program
Xeltis announced today that is planning to accelerate its clinical trial program for three restorative devices in parallel. CEO Eliane Schutte provided a sneak preview on Xeltis’ plans to an audience of investors and medtech companies at the Medtech and Diagnostics Forum organised by the investment bank Canaccord Genuity Capital Markets. Xeltis currently has three restorative devices in ...
By XELTIS BV
-
Flat Medical announced FDA 510(k) clearance of EpiFaith, the Epidural Safety Solution
Flat Medical Co., Ltd., the medtech company specializing in clinical safety solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration for its EpiFaith® syringe to deliver safe epidural locating solution. Based on the LOR technique, the EpiFaith® syringe is a physician-centered safeguard for epidural analgesia, which is indicated for painless labor, ...
By Flat Medical
-
Nalu Medical Named Best MedTech Company and Medical Device in Field of Neurology
Nalu Medical is pleased to announce its flagship micro-Implantable Pulse Generator (mIPG™) was selected as the 2021 winner of the MedTech Visionaries Award for Best MedTech Company and Best Medical Device in the field of neurology. The MedTech Visionaries Awards honor organizations that apply science and technology to real-world problems to advance MedTech solutions for businesses and ...
-
TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Ruth Krestin as Vice President of Portfolio Strategy within TISSIUM. In this role, she will be responsible for coordinating TISSIUM’s verticals and driving an efficient portfolio-level strategy. Ms. Krestin joins TISSIUM with extensive ...
By TISSIUM
-
TISSIUM to present study results at the Hernia 2021 European Hernia Society - American Hernia Society Joint Congress
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, will present an e-poster on its research on a novel, atraumatic, and consistent hernia mesh fixation device at the Hernia 2021 European Hernia Society – American Hernia Society Joint Congress. The event is scheduled to be held virtually and in-person from October 13 – ...
By TISSIUM
-
TISSIUM selected for the French Tech 120 Program
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has been nominated in the French Tech 120 of the 2022 program. French Tech 120 is a growth-stage program by La FrenchTech, built to provide government-backed support for the 120 fastest growing companies in France. This is the third year in a row that ...
By TISSIUM
-
TISSIUM Selected for French Tech 120 Program
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has been named a French Tech 120 company for the 2021 program. French Tech 120 is a growth-stage program by La French Tech, built to provide government-backed support for the 120 fastest growing companies in France. This is the second year in a row that ...
By TISSIUM
-
Invizius attracts £2.75m Pre-Series A investment
Invizius, the University of Edinburgh spin-out whose technology could help reduce the high death rates amongst dialysis patients, has raised £2.75m from a consortium of investors. The funding round was led by Mercia and included Downing Ventures, the University’s Old College Capital fund and the Scottish Investment Bank. The latest investment will support the company as it conducts ...
-
TISSIUM to present study results at the 76th Annual Meeting of the American Society for Surgery of the Hand
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has announced its research has been selected for presentation within the scientific program at the 76th Annual Meeting of the American Society for Surgery of the Hand. The event is scheduled to be held virtually and in-person from September 30 – October 2, 2021 in San Francisco, ...
By TISSIUM
-
iSTAR Medical appoints leading glaucoma specialist Prof. Kaweh Mansouri as Chief Medical Officer
WAVRE, Belgium — 6 September 2022: iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, today announces the appointment of Dr Kaweh Mansouri as Chief Medical Officer (CMO). Dr Mansouri is a medical and surgical eye specialist, sub-specializing in glaucoma and cataract. Currently a Consultant Ophthalmologist at the Glaucoma Center, Swiss Visio, ...
-
Fierce Medtech names MeMed as one of its ‘Fierce 15’ medical technology companies
MeMed today announced that it has been named by Fierce Medtech as one of its ‘Fierce 15’ medical technology companies of 2021, designating it as one of the most promising private medtech companies in the industry. MeMed is a leader in the emerging field of advanced host-response technologies with a portfolio of solutions designed to provide actionable insights for tough clinical ...
By MeMed
-
KLISBio to share innovative tissue-engineered technology at LSI 2022 Emerging MedTech Summit
Milan, Italy (March 14, 2022) – Today, KLISBio, a MedTech company challenging the status quo in regenerative medicine by leveraging a silk-based multidisciplinary technology platform, announced its attendance to LSI 2022 Emerging MedTech Summit. LSI Annual Meeting will be held March 15 -18, 2022 in Dana Point – CA. KLISBio’s designated attendee to LSI Emerging MedTech Summit ...
By KLISBio
-
KLISBio to present SILKBridge for peripheral nerve repair and its innovative silk-based tissue-engineered technology platform at 2022 Bio€quity Europe
Milan, Italy (May 11, 2022) – Today, KLISBio, a MedTech company challenging the status quo in regenerative medicine by leveraging a silk-based multidisciplinary technology platform, announced its attendance to 2022 Bio€quity Europe. 2022 Bio€quity Europe will be held May 16 -18, 2022 in Milan – Italy. Antonio Alessandrino, CTO and Founder of KLISBio, will be presenting on ...
By KLISBio
-
US FDA awards Breakthrough Device Designation to Australian labour monitoring device, Oli
BaymatobTM, a MedTech company founded by a Sydney mother after her own traumatic birth experience, has developed a world-first labour monitoring device that has achieved US Food and Drug Administration (FDA) Breakthrough Device Designation. This sets Baymatob’s game changing maternal diagnostic tool called OliTM on an streamlined and supported path toward regulatory approval. Oli seeks to ...
-
TISSIUM Receives FDA Investigational Device Exemption for Vascular Sealant
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has received approval from the U.S. Food and Drug Administration for its Investigational Device Exemption application for its vascular sealant. The approval is the most recent validation of TISSIUM’s efforts to develop a unique platform of proprietary ...
By TISSIUM
-
MedTech Innovator Names Sana Health as 2018 Global Competition Winner at The MedTech Conference
MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, today announced Sana Health as the winner of its 2018 global competition. The company was selected in a live audience vote on Sept. 25 at The MedTech Conference, powered by AdvaMed, in Philadelphia. Sana Health, a medical technology startup based in Boulder, Colo., is developing a non-invasive ...
By Strados Labs
-
Axio Biosolutions raises $6 million in a Series B2 equity round led by TrueScale Capital
Axio Biosolutions, a pioneering MedTech company, today announced a $6 million Series B2 equity raise led by TrueScale Capital, with participation from existing investors Omidyar Network India, University of California– Ratan Tata Fund, and Accel. Axio Biosolutions Private Limited, India (“Axio”), a wholly owned subsidiary of Boston-based Advamedica Inc. is a leading developer of ...
-
Q’Apel Medical Welcomes Jodie Fam, Vice President and General Manager, International
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, is pleased to announce and welcome Jodie Fam as Vice President and General Manager, International. Jodie will be responsible for the leadership and development of International Sales for Q’Apel. Jodie brings more than 20 ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you